Trial
NCT00402883
Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer
Phase IITERMINATEDSAFETYConfidence: HIGH
Sponsor
SCRI Development Innovations, LLC
Collaborators
Genentech, Inc.; Eli Lilly and Company
Condition
Lung Cancer
Intervention
Bevacizumab
Why stopped
Terminated due to bevacizumab and chemoradiotherapy toxicity
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-11-09